VYNE Therapeutics Inc. (VYNE): SCHEDULE 13G filed Aug 7, 2026

Form type

SCHEDULE 13G

Filing date

Aug 7, 2026

Accession number

0001274173-26-000185

Filer

VYNE Therapeutics Inc. (CIK 1566044)